ACHIEVE LIFE SCIENCES, INC. — Director's Dealing 2013

Oct 7, 2013

SEC Form 4/A — Form 4/A

Issuer: ONCOGENEX PHARMACEUTICALS, INC. (OGXI)
CIK: 0000949858
Period of Report: 2013-03-12

Reporting Person: JACOBS CINDY (EVP, CMO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-03-12	Common Stock	S	534	$11.90	Disposed	22551	Direct

Footnotes

F1: This amended Form 4 is filed to correct the transaction code, which was previously inadvertently reported as "F", and the sales price. The sales reported on this amended Form 4 were made for the sole purpose of covering the reporting person's tax liability in connection with the settlement of RSUs on March 12, 2013, which transaction was previously reported.